Inflammatory response to Trichomonas vaginalis in the pathogenesis of prostatitis and benign prostatic hyperplasia
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Trichomonas vaginalis is a flagellated protozoan that causes trichomoniasis, a common nonviral sexually transmitted infection. T. vaginalis infection is asymptomatic in most infected men but can lead to chronic infection. The inflammatory response to chronic T. vaginalis infection may contribute to prostatic diseases, such as prostatitis and benign prostatic hyperplasia (BPH); however, studies on the relationship between T. vaginalis infection and prostate diseases are scarce. In this review, we discuss evidence from our studies on the involvement of T. vaginalis in the pathogenesis of prostate diseases, such as prostatitis and BPH. Studies of prostatitis have demonstrated that the attachment of T. vaginalis trophozoite to prostate epithelial cells (PECs) induces inflammatory cytokine production and inflammatory cell migration, leading to prostatitis. T. vaginalis also causes pathological changes, such as inflammatory cell infiltration, acinar changes, interstitial fibrosis, and mast cell infiltration, in prostate tissues of infected rats. Thus, T. vaginalis is considered an infectious agent that triggers prostatitis. Meanwhile, studies of prostatic hyperplasia revealed that mast cells activated by T. vaginalis-infected prostate cells secreted inflammatory mediators, such as β-hexosaminidase and tryptase, which promoted proliferation of prostate stromal cell (PSC). Moreover, interleukin-6 produced by proliferating PSCs induced the multiplication of BPH-1 epithelial cells as a result of stromal–epithelial interaction, suggesting that the proliferation of T. vaginalis-infected prostate cells can be induced through crosstalk with mast cells. These collective findings suggest that T. vaginalis contributes to the progression of prostatitis and prostatic hyperplasia by creating an inflammatory microenvironment involving PECs and PSCs.
Abstract
Trichomonas vaginalis is a flagellated protozoan that causes trichomoniasis, a common nonviral sexually transmitted infection. T. vaginalis infection is asymptomatic in most infected men but can lead to chronic infection. The inflammatory response to chronic T. vaginalis infection may contribute to prostatic diseases, such as prostatitis and benign prostatic hyperplasia (BPH); however, studies on the relationship between T. vaginalis infection and prostate diseases are scarce. In this review, we discuss evidence from our studies on the involvement of T. vaginalis in the pathogenesis of prostate diseases, such as prostatitis and BPH. Studies of prostatitis have demonstrated that the attachment of T. vaginalis trophozoite to prostate epithelial cells (PECs) induces inflammatory cytokine production and inflammatory cell migration, leading to prostatitis. T. vaginalis also causes pathological changes, such as inflammatory cell infiltration, acinar changes, interstitial fibrosis, and mast cell infiltration, in prostate tissues of infected rats. Thus, T. vaginalis is considered an infectious agent that triggers prostatitis. Meanwhile, studies of prostatic hyperplasia revealed that mast cells activated by T. vaginalis-infected prostate cells secreted inflammatory mediators, such as β-hexosaminidase and tryptase, which promoted proliferation of prostate stromal cell (PSC). Moreover, interleukin-6 produced by proliferating PSCs induced the multiplication of BPH-1 epithelial cells as a result of stromal–epithelial interaction, suggesting that the proliferation of T. vaginalis-infected prostate cells can be induced through crosstalk with mast cells. These collective findings suggest that T. vaginalis contributes to the progression of prostatitis and prostatic hyperplasia by creating an inflammatory microenvironment involving PECs and PSCs.
참고문헌 (83)
- 천상훈, "The Dimension of Trichomonas vaginalis as Measured by Scanning Electron Microscopy", Parasites, Hosts and Diseases, 51(2), pp.243~246 (2013), 대한기생충학ㆍ열대의학회
- Global health sectors strategy on sexually transmitted infections 2016-2021, "World Health Organization", World Health Organization, ~ (2016)
- McClelland RS, "Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition", J Infect Dis, 195(5), pp.698~702 (2007)[DOI]
- McNeal JE, "Anatomy of the prostate and morphogenesis of BPH", Prog Clin Biol Res, 145, pp.27~53 (1984)
- Leach DA, "Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome", Oncotarget, 6(18), pp.16135~16150 (2015)[DOI]
- Lilja H, "Three predominant proteins secreted by the human prostate gland", Prostate, 12(1), pp.29~38 (1988)[DOI]
- Sfanos KS, "The inflammatory microenvironment and microbiome in prostate cancer development", Nat Rev Urol, 15(1), pp.11~24 (2018)[DOI]
- Gatti G, "Expression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer", Prostate, 69(13), pp.1387~1397 (2009)[DOI]
- Gambara G, "Toll-like receptors in prostate infection and cancer between bench and bedside", J Cell Mol Med, 17(6), pp.713~722 (2013)[DOI]
- Manning ML, "Proteolysis of complement factors iC3b and C5 by the serine protease prostate-specific antigen in prostatic fluid and seminal plasma", J Immunol, 190(6), pp.2567~2574 (2013)[DOI]
- Fowler JE Jr, "Longitudinal studies of prostatic fluid immunoglobulin in men with bacterial prostatitis", J Urol, 131(2), pp.363~369 (1984)[DOI]
- Isaacs JT, "Prostatic structure and function in relation to the etiology of prostatic cancer", Prostate, 4(4), pp.351~366 (1983)[DOI]
- Gardner WA Jr, "Trichomonas vaginalis in the prostate gland", Arch Pathol Lab Med, 110(5), pp.430~432 (1986)
- Mitteregger D, "High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue", Med Microbiol Immunol, 20(1), pp.113~116 (2012)[DOI]
- Iqbal J, "Detection of Trichomonas vaginalis in prostate tissue and serostatus in patients with asymptomatic benign prostatic hyperplasia", BMC Infect Dis, 16(1), pp.506~ (2016)[DOI]
- Thumbikat P, "Prostate secretions from men with chronic pelvic pain syndrome inhibit proinflammatory mediators", J Urol, 184(4), pp.1536~1542 (2010)[DOI]
- Skerk V, "Aetiology of chronic prostatitis", Int J Antimicrob Agents, 19(6), pp.471~474 (2002)[DOI]
- Skerk V, "The role of unusual pathogens in prostatitis syndrome", Int J Antimicrob Agents, 24(suppl 1), pp.53~56 (2004)[DOI]
- Jong Jin Lee, "PCR for Diagnosis of Male Trichomonas vaginalis Infection with Chronic Prostatitis and Urethritis", Parasites, Hosts and Diseases, 50(2), pp.157~159 (2012), 대한기생충학ㆍ열대의학회[DOI]
- Jun-Hyeok Seo, "Prevalence of Trichomonas vaginalis by PCR in men attending a primary care urology clinic in South Korea", Parasites, Hosts and Diseases, 52(5), pp.551~555 (2014), 대한기생충학ㆍ열대의학회[DOI]
- Alderete JF, "Pathogenic Trichomonas vaginalis cytotoxicity to cell culture monolayers", Br J Vener Dis, 60(2), pp.99~105 (1984)[DOI]
- Alderete JF, "Specific nature of Trichomonas vaginalis parasitism of host cell surfaces", Infect Immun, 50(3), pp.701~708 (1985)[DOI]
- Arroyo R, "Signalling of Trichomonas vaginalis for amoeboid transformation and adhesion synthesis follows cytoadherence", Mol Microbiol, 7(2), pp.299~309 (1993)[DOI]
- Kim SR, "Scanning electron microscopic observation of Trichomonas vaginalis contacted with human vaginal epithelial cells", Korean J Electron Microscopy, 31(3), pp.235~244 (2001)
- 김정현, "Interaction between Trichomonas vaginalis and the Prostate Epithelium", Parasites, Hosts and Diseases, 55(2), pp.213~218 (2017), 대한기생충학ㆍ열대의학회[DOI]
- Han IH, "Signalling pathways associated with IL-6 production and epithelial-mesenchymal transition induction in prostate epithelial cells stimulated with Trichomonas vaginalis", Parasite Immunol, 38(11), pp.678~687 (2016)[DOI]
- Seo MY, "Inflammatory Response of Prostate Epithelial Cells to Stimulation by Trichomonas vaginalis", Prostate, 74, pp.441~449 (2014)[DOI]
- Kashyap M, "Inflammasomes are important mediators of prostatic inflammation associated with BPH", J Inflamm(Lond), 12, pp.37~ (2015)[DOI]
- Chen CS, "Evidences of the inflammasome pathway in chronic prostatitis and chronic pelvic pain syndrome in an animal model", Prostate, 73(4), pp.391~397 (2013)[DOI]
- Dinarello CA, "Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process", Am J Clin Nutr, 83(2), pp.447S~455S (2006)[DOI]
- Martinon F, "Inflammatory caspases : linking an intracellular innate immune system to autoinflammatory diseases", Cell, 117(5), pp.561~574 (2004)[DOI]
- Elinav E, "Regulation of the antimicrobial response by NLR proteins", Immunity, 34(5), pp.665~679 (2011)[DOI]
- Gu NY, "Trichomonas vaginalis induces IL-1 beta production in a human prostate epithelial cell line by activating the NLRP3 inflammasome via reactive oxygen species and potassium ion efflux", Prostate, 76(10), pp.885~896 (2016)[DOI]
- Nguyen DP, "Inflammation and prostate cancer : the role of interleukin 6(IL-6)", BJU Int, 113(6), pp.986~992 (2014)[DOI]
- Bardan R, "The role of prostatic inflammation biomarkers in the diagnosis of prostate diseases", Clin Biochem, 47(10-11), pp.909~915 (2014)[DOI]
- Sutcliffe S, "Trichomonosis, a common curable STI, and prostate carcinogenesis-a proposed molecular mechanism", PLoS Pathog, 8(8), pp.e1002801~ (2012)[DOI]
- Thomson AA, "Prostate development and pathogenesis", Differentiation, 76(6), pp.559~564 (2008)[DOI]
- Tuxhorn JA, "Reactive stroma in prostate cancer progression", J Urol, 166(6), pp.2472~2483 (2001)
- Im SJ, "Inflammatory response of a prostate stromal cell line induced by Trichomonas vaginalis", Parasite Immunol, 38(4), pp.218~227 (2016)[DOI]
- Jang KS, "Experimental rat prostatitis caused by Trichomonas vaginalis infection", Prostate, 79(4), pp.379~389 (2019)[DOI]
- Bostwick DG, "Textbook of Benign Prostate Hyperplasia", pp.97~112 (2002), Isis Medical Media
- De Nunzio C, "Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia", World J Urol, 38, pp.2771~2779 (2020)[DOI]
- Gravas S, "Management of Non-Neurogenic Male LUTS", EAU Guidelines Office, ~ (2022)
- Devlin CM, "Benign prostatic hyperplasia-what do we know?", BJU Int, 127(4), pp.389~399 (2021)[DOI]
- De Nunzio C, "Inflammatory mediators in the development and progression of benign prostatic hyperplasia", Nat Rev Urol, 13(10), pp.613~626 (2016)[DOI]
- Ficarra V, "Why and how to evaluate chronic prostatic inflammation", Eur Urol Suppl, 12(5), pp.110~115 (2013)[DOI]
- De Marzo AM, "Inflammation in prostate carcinogenesis", Nat Rev Cancer, 7(4), pp.256~269 (2007)[DOI]
- Breyer BN, "Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes : results from the prostate, lung, colorectal and ovarian cancer screening trial", BJU Int, 117(1), pp.145~154 (2016)[DOI]
- Twu O, "Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses", Proc Natl Acad Sci U S A, 111(22), pp.8179~8184 (2014)[DOI]
- Claus S, "Immunohistochemical determination of age related proliferation rates in normal and benign hyperplastic human prostates", Urol Res, 21(5), pp.305~308 (1993)[DOI]
- Ou Z, "Infiltrating mast cells enhance benign prostatic hyperplasia through IL-6", STAT3, Oncotarget, pp.2017, 8(35)[DOI]
- Romih R, "Recent advances in the biology of the urothelium and applications for urinary bladder dysfunction", Biomed Res Int, 2014, pp.341787~ (2014)[DOI]
- Pattabiraman G, "Mast cell function in prostate inflammation, fibrosis, and smooth muscle cell dysfunction", Am J Physiol Renal Physiol, 321(4), pp.F466~F479 (2021)[DOI]
- Kobayashi TK, "Association of mast cells with vaginal trichomoniasis in endocervical smears", Acta cytol, 27(2), pp.133~137 (1983)
- Im SJ, "Histamine and TNF-alpha release by rat peritoneal mast cells stimulated with Trichomonas vaginalis", Parasite, 18(1), pp.49~55 (2011)[DOI]
- Han IH, "Involvement of mast cells in inflammation induced by Trichomonas vaginalis via crosstalk with vaginal epithelial cells", Parasite Immunol, 34(1), pp.8~14 (2012)[DOI]
- Beghdadi W, "Mast cells as cellular sensors in inflammation and immunity", Front Immunol, 2, pp.37~ (2011)[DOI]
- Krystel-Whittemore M, "Mast cell : a multi-functional master cell", Front Immunol, 6, pp.620~ (2015)[DOI]
- Overed-Sayer C, "Are mast cells instrumental for fibrotic diseases?", Front Pharmacol, 4, pp.174~ (2014)[DOI]
- Sang-Su Kim, "Inflammatory Responses in a Benign Prostatic Hyperplasia Epithelial Cell Line (BPH-1) Infected with Trichomonas vaginalis", Parasites, Hosts and Diseases, 54(2), pp.123~132 (2016), 대한기생충학ㆍ열대의학회
- Kim JH, "Proliferation of prostate stromal cell induced by benign prostatic hyperplasia epithelial cell stimulated with Trichomonas vaginalis via crosstalk with mast cell", Prostate, 76(15), pp.1431~1444 (2016)[DOI]
- Duchesne E, "Mast cell tryptase stimulates myoblast proliferation; a mechanism relying on protease-activated receptor-2 and cyclooxygenase-2", BMC Musculoskelet Disord, 12, pp.235~ (2011)[DOI]
- Bagher M, "Mast cells and mast cell tryptase enhance migration of human lung fibroblasts through protease-activated receptor 2", Cell Commun Signal, 16(1), pp.59~ (2018)[DOI]
- Murray DB, "Tryptase activates isolated adult cardiac fibroblasts via protease activated receptor-2(PAR-2)", J Cell Commun Signal, 6(1), pp.45~51 (2012)[DOI]
- Borensztajn K, "Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury : potential role in pulmonary fibrosis", Am J Pathol, 177(6), pp.2753~2764 (2010)[DOI]
- Roman K, "Role of PAR2 in the development of lower urinary tract dysfunction", J Urol, 196(2), pp.588~598 (2016)[DOI]
- Noh CS, "Mast cell tryptase-PAR2 pathway in proliferation of prostatic stromal cells reacted with Trichomonas vaginalis", Parasite Immunol, 43(8), pp.e12868~ (2021)[DOI]
- Lokeshwar SD, "Epidemiology and treatment modalities for the management of benign prostatic hyperplasia", Transl Androl Urol, 8(5), pp.529~539 (2019)[DOI]
- Kogan-Sakin I, "Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3and IL-8 in response to epithelia-secreted IL-1", Carcinogenesis, 30(4), pp.698~705 (2009)[DOI]
- Siejka A, "The effect of LHRH antagonist cetrorelix in crossover conditioned media from epithelial(BPH-1)and stromal(WPMY-1)prostate cells", Horm Metab Res, 46(1), pp.21~26 (2014)[DOI]
- Kim JH, "Proliferation of prostate epithelia induced by IL-6 from stroma reacted with Trichomonas vaginalis", Parasite Immunol, 40(6), pp.e12531~ (2018)[DOI]
- Lamouille S, "Molecular mechanisms of epithelial-mesenchymal transition", Nat Rev Mol Cell Biol, 15, pp.178~196 (2014)[DOI]
- Han IH, "Inflammatory mediators of prostate epithelial cells stimulated with Trichomonas vaginalis promote proliferative and invasive properties of prostate cancer cells", Prostate, 79(10), pp.1133~1146 (2019)[DOI]
- Alonso-Magdalena P, "A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia", Proc Natl Acad Sci U S A, 106(8), pp.2859~2863 (2009)[DOI]
- Shi X, "Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells", Prostate, 77(14), pp.1424~1437 (2017)[DOI]
- Hu S, "Evidence of TGF-B1mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells", Mol Mem Biol, 31(2-3), pp.103~110 (2014)[DOI]
- 정재흥, "Obesity as a Risk Factor for Prostatic Enlargement: A Retrospective Cohort Study in Korea", International Neurourology Journal, 20(4), pp.321~328 (2016), 대한배뇨장애요실금학회
- Lee RK, "Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms", BJU Int, 110(4), pp.540~545 (2012)[DOI]
- Sieminska L, "Serum concentrations of adipokines in men with prostate cancer and benign prostate hyperplasia", Endokrynol Pol, 69(2), pp.120~127 (2018)[DOI]
- Margetic S, "Leptin : a review of its peripheral actions and interactions", Int J Obes Relat Metab Disord, 26, pp.1407~1433 (2002)[DOI]
- Szyszka M, "Effects of leptin on leptin receptor isoform expression and proliferative activity in human normal prostate and prostate cancer cell lines", Oncol Rep, 39(1), pp.182~192 (2018)[DOI]
- Habib CN, "Leptin influences estrogen metabolism and accelerates prostate cell proliferation", Life Sci, 121, pp.10~15 (2015)[DOI]
- 김정현, "Signaling Role of Adipocyte Leptin in Prostate Cell Proliferation Induced by Trichomonas vaginalis", Parasites, Hosts and Diseases, 59(3), pp.235~249 (2021), 대한기생충학ㆍ열대의학회[DOI]
